Formation of Self-Assembled Liquid Crystalline Nanoparticles and Absorption Enhancement of Ω-3s by Phospholipids and Oleic Acids

Overview

Journal Pharmaceutics

Publisher MDPI

Date 2022 Jan 21

PMID 35056964

Authors

Sang-Won Jeon

Han-Sol Jin

Young-Joon Park

Affiliations

Soon will be listed here.

Abstract

This study aimed to optimize and evaluate self-assembled liquid crystalline nanoparticles (SALCs) prepared from phospholipids and oleic acid for enhancing the absorption of Ω-3s. We explored the structure and optimal formulation of SALCs, which are composed of Ω-3 ethyl ester (Ω-3 EE), phospholipids, and oleic acid, using a ternary diagram and evaluated the improvement in Ω-3 dissolution, permeation, and oral bioavailability. The in vitro dissolution and pharmacokinetics of Ω-3 SALCs were compared with those of Omacor soft capsules (as the reference). The shape of the liquid crystal was determined according to the composition of phospholipids, oleic acids, and Ω-3s and was found to be in cubic, lamellar, and hexagonal forms. The dissolution rates of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) obtained from Ω-3 SALCs were 1.7 to 2.3-fold higher than those of the Omacor soft capsules. Furthermore, a pharmacokinetic study in male beagle dogs revealed that Ω-3 SALCs increased the oral bioavailability of Ω-3 EE by 2.5-fold for EPA and 3.1-fold for DHA compared with the reference. We found an optimal formulation that spontaneously forms liquid crystal-based nanoparticles, improving the bioavailability of EPA and DHA, not found in the existing literature. Our findings offer insight into the impact of nanoparticle phase on the oral delivery of oil-soluble drugs and provide a novel Ω-3 EE formulation that improves the bioavailability of EPA and DHA.

Citing Articles

The potential molecular markers of inflammatory response in KOA with AD based on single-cell transcriptome sequencing analysis and identification of ligands by virtual screening.

Wu Y, Chen W, Jian J, Liu W, Wang H, Gao D Mol Divers. 2024; 29(1):319-336.

PMID: 38622351 DOI: 10.1007/s11030-024-10854-4.

A Randomized, Open-Label, Single-Dose, Crossover Study of the Comparative Bioavailability of EPA and DHA in a Novel Liquid Crystalline Nanoparticle-Based Formulation of ω-3 Acid Ethyl Ester Versus Omacor Soft Capsule among Healthy Adults.

Kang K, Jeon S, De A, Hong T, Park Y Int J Mol Sci. 2023; 24(24).

PMID: 38139029 PMC: 10743492. DOI: 10.3390/ijms242417201.

Traditional Chinese Medicine Shi-Bi-Man regulates lactic acid metabolism and drives hair follicle stem cell activation to promote hair regeneration.

Du H, Zhang T, Wang Q, Cao X, Zheng H, Li J Chin Med. 2023; 18(1):84.

PMID: 37454125 PMC: 10349503. DOI: 10.1186/s13020-023-00791-z.

Recent Advances in the Development of Liquid Crystalline Nanoparticles as Drug Delivery Systems.

Leu J, Teoh J, Ling A, Chong J, Loo Y, Azmi I Pharmaceutics. 2023; 15(5).

PMID: 37242663 PMC: 10224018. DOI: 10.3390/pharmaceutics15051421.

Microemulsions Enhance the In Vitro Antioxidant Activity of Oleanolic Acid in RAW 264.7 Cells.

De Stefani C, Vasarri M, Salvatici M, Grifoni L, Quintela J, Bilia A Pharmaceutics. 2022; 14(10).

PMID: 36297667 PMC: 9610975. DOI: 10.3390/pharmaceutics14102232.

References

Shimada H, Nilsson C, Noda Y, Kim H, Lundstrom T, Yajima T . Effects of Food on the Pharmacokinetics of Omega-3-Carboxylic Acids in Healthy Japanese Male Subjects: A Phase I, Randomized, Open-label, Three-period, Crossover Trial. J Atheroscler Thromb. 2017; 24(9):980-987. PMC: 5587524. DOI: 10.5551/jat.38737. View

Lidich N, Aserin A, Garti N . Structural characteristics of oil-poor dilutable fish oil omega-3 microemulsions for ophthalmic applications. J Colloid Interface Sci. 2015; 463:83-92. DOI: 10.1016/j.jcis.2015.10.024. View

El Boustani S, Colette C, Monnier L, Descomps B, CRASTES DE PAULET A, Mendy F . Enteral absorption in man of eicosapentaenoic acid in different chemical forms. Lipids. 1987; 22(10):711-4. DOI: 10.1007/BF02533970. View

Shalaev E, Wu K, Shamblin S, Krzyzaniak J, Descamps M . Crystalline mesophases: Structure, mobility, and pharmaceutical properties. Adv Drug Deliv Rev. 2016; 100:194-211. DOI: 10.1016/j.addr.2016.04.002. View

Um J, Chung H, Kim K, Kwon I, Jeong S . In vitro cellular interaction and absorption of dispersed cubic particles. Int J Pharm. 2003; 253(1-2):71-80. DOI: 10.1016/s0378-5173(02)00673-7. View

Trebaticka J, Hradecna Z, Surovcova A, Katrencikova B, Gushina I, Waczulikova I . Omega-3 fatty-acids modulate symptoms of depressive disorder, serum levels of omega-3 fatty acids and omega-6/omega-3 ratio in children. A randomized, double-blind and controlled trial. Psychiatry Res. 2020; 287:112911. DOI: 10.1016/j.psychres.2020.112911. View

Moyad M . An introduction to dietary/supplemental omega-3 fatty acids for general health and prevention: part II. Urol Oncol. 2005; 23(1):36-48. DOI: 10.1016/j.urolonc.2005.03.001. View

Rajabalaya R, Musa M, Kifli N, David S . Oral and transdermal drug delivery systems: role of lipid-based lyotropic liquid crystals. Drug Des Devel Ther. 2017; 11:393-406. PMC: 5315216. DOI: 10.2147/DDDT.S103505. View

Naiemian S, Naeemipour M, Zarei M, Najafi M, Gohari A, Behroozikhah M . Serum concentration of asprosin in new-onset type 2 diabetes. Diabetol Metab Syndr. 2020; 12:65. PMC: 7376837. DOI: 10.1186/s13098-020-00564-w. View

10.

Bergstrom C, Holm R, Jorgensen S, Andersson S, Artursson P, Beato S . Early pharmaceutical profiling to predict oral drug absorption: current status and unmet needs. Eur J Pharm Sci. 2013; 57:173-99. DOI: 10.1016/j.ejps.2013.10.015. View

11.

Angelova A, Drechsler M, Garamus V, Angelov B . Liquid Crystalline Nanostructures as PEGylated Reservoirs of Omega-3 Polyunsaturated Fatty Acids: Structural Insights toward Delivery Formulations against Neurodegenerative Disorders. ACS Omega. 2018; 3(3):3235-3247. PMC: 6044969. DOI: 10.1021/acsomega.7b01935. View

12.

Kim S, Thiessen P, Bolton E, Chen J, Fu G, Gindulyte A . PubChem Substance and Compound databases. Nucleic Acids Res. 2015; 44(D1):D1202-13. PMC: 4702940. DOI: 10.1093/nar/gkv951. View

13.

Timmis A, Townsend N, Gale C, Grobbee R, Maniadakis N, Flather M . European Society of Cardiology: Cardiovascular Disease Statistics 2017. Eur Heart J. 2017; 39(7):508-579. DOI: 10.1093/eurheartj/ehx628. View

14.

Jing S, Zhang Z, Chen X, Miao R, Nilsson C, Lin Y . Pharmacokinetics of Single and Multiple Doses of Omega-3 Carboxylic Acids in Healthy Chinese Subjects: A Phase I, Open-Label Study. Clin Pharmacol Drug Dev. 2020; 9(8):985-994. DOI: 10.1002/cpdd.800. View

15.

Azmi I, Wibroe P, Wu L, Kazem A, Amenitsch H, Moghimi S . A structurally diverse library of safe-by-design citrem-phospholipid lamellar and non-lamellar liquid crystalline nano-assemblies. J Control Release. 2016; 239:1-9. DOI: 10.1016/j.jconrel.2016.08.011. View

16.

Shin H, Kim J, Park Y . Nanoporous Silica Entrapped Lipid-Drug Complexes for the Solubilization and Absorption Enhancement of Poorly Soluble Drugs. Pharmaceutics. 2021; 13(1). PMC: 7825318. DOI: 10.3390/pharmaceutics13010063. View

17.

Schuchardt J, Hahn A . Bioavailability of long-chain omega-3 fatty acids. Prostaglandins Leukot Essent Fatty Acids. 2013; 89(1):1-8. DOI: 10.1016/j.plefa.2013.03.010. View

18.

Tran N, Mulet X, Hawley A, Fong C, Zhai J, Le T . Manipulating the Ordered Nanostructure of Self-Assembled Monoolein and Phytantriol Nanoparticles with Unsaturated Fatty Acids. Langmuir. 2018; 34(8):2764-2773. DOI: 10.1021/acs.langmuir.7b03541. View

19.

Arshad R, Tabish T, Kiani M, Ibrahim I, Shahnaz G, Rahdar A . A Hyaluronic Acid Functionalized Self-Nano-Emulsifying Drug Delivery System (SNEDDS) for Enhancement in Ciprofloxacin Targeted Delivery against Intracellular Infection. Nanomaterials (Basel). 2021; 11(5). PMC: 8146397. DOI: 10.3390/nano11051086. View

20.

Li J, Zhu N, Zhu J, Zhang W, Zhang H, Wang Q . Self-Assembled Cubic Liquid Crystalline Nanoparticles for Transdermal Delivery of Paeonol. Med Sci Monit. 2015; 21:3298-310. PMC: 4632989. DOI: 10.12659/msm.894484. View